Trial of Daily Pulse Interleukin-2 With Famotidine in Acute Myelogenous Leukemia
NCT01289678
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
18
Enrollment
OTHER
Sponsor class
Stopped
Unable to meet accrual goals
Conditions
Acute Myelogenous Leukemia
Interventions
DRUG:
Interleukin-2
Sponsor
Leo W. Jenkins Cancer Center